Haemonetics (NYSE:HAE) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.11 by 14.41 percent. This is a 13.39 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $327.316 million which beat the analyst consensus estimate of $311.399 million by 5.11 percent. This is a 5.27 percent decrease over sales of $345.511 million the same period last year.